Literature DB >> 9505195

Interleukin 9 and its receptor: an overview of structure and function.

J B Demoulin1, J C Renauld.   

Abstract

Interleukin-9 (IL-9) is a multifunctional cytokine produced by activated TH2 clones in vitro and during TH2-like T cell responses in vivo. Although IL-9 was initially described as a T cell growth factor, its role in T cell responses is still unclear. While freshly isolated normal T cells do not respond to IL-9, this cytokine induces the proliferation of murine T cell lymphomas in vitro, and in vivo overexpression of IL-9 results in the development of thymic lymphomas. In the human, the existence of an IL-9 mediated autocrine loop has been suggested for some malignancies such as Hodgkin's disease. Various observations indicate that IL-9 is actively involved in mast cells responses by inducing the proliferation and differentiation of these cells. Other potential biological targets for IL-9 include B lymphocytes, and hematopoietic progenitors, for which higher responses were observed with foetal or transformed cells as compared to normal adult progenitors. The IL-9 receptor is a member of the hemopoietin receptor superfamily and interacts with the gamma chain of the IL-2 receptor for signaling. Signal transduction studies have stressed the role of the Jak-STAT pathway in various IL-9 bioactivities, whereas the 4PS/IRS2 adaptor protein might also play a significant role in IL-9 signaling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9505195     DOI: 10.3109/08830189809043001

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  26 in total

1.  Searching for signals of evolutionary selection in 168 genes related to immune function.

Authors:  Emily C Walsh; Pardis Sabeti; Holli B Hutcheson; Ben Fry; Stephen F Schaffner; Paul I W de Bakker; Patrick Varilly; Alejandro A Palma; Jessica Roy; Richard Cooper; Cheryl Winkler; Yi Zeng; Guy de The; Eric S Lander; Stephen O'Brien; David Altshuler
Journal:  Hum Genet       Date:  2005-12-14       Impact factor: 4.132

Review 2.  Mucin overproduction in chronic inflammatory lung disease.

Authors:  Hans-Peter Hauber; Susan C Foley; Qutayba Hamid
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

3.  Association between low expression levels of interleukin-9 and colon cancer progression.

Authors:  Yonghong Huang; Yunfei Cao; Sen Zhang; Feng Gao
Journal:  Exp Ther Med       Date:  2015-06-23       Impact factor: 2.447

4.  Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections.

Authors:  W I Khan; M Richard; H Akiho; P A Blennerhasset; N E Humphreys; R K Grencis; J Van Snick; S M Collins
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Distinct spatial relationship of the interleukin-9 receptor with interleukin-2 receptor and major histocompatibility complex glycoproteins in human T lymphoma cells.

Authors:  Enikő Nizsalóczki; István Csomós; Péter Nagy; Zsolt Fazekas; Carolyn K Goldman; Thomas A Waldmann; Sándor Damjanovich; György Vámosi; László Mátyus; Andrea Bodnár
Journal:  Chemphyschem       Date:  2014-10-08       Impact factor: 3.102

6.  IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells.

Authors:  Akira Yamasaki; Ali Saleh; Latifa Koussih; Shigeo Muro; Andrew J Halayko; Abdelilah S Gounni
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

7.  Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye.

Authors:  Tony Lin; Gregory Brett Walker; Khaliq Kurji; Edward Fang; Geoffrey Law; Shiv S Prasad; Luba Kojic; Sijia Cao; Valerie White; Jing Z Cui; Joanne A Matsubara
Journal:  Cytokine       Date:  2013-04-17       Impact factor: 3.861

8.  Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.

Authors:  Jing Chen; Mike Petrus; Bonita R Bryant; Vinh Phuc Nguyen; Mindy Stamer; Carolyn K Goldman; Richard Bamford; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2008-03-13       Impact factor: 22.113

9.  Evaluation of Interleukin-9 Expression as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia in a Cohort of Egyptian Patients.

Authors:  Hadeer A Abbassy; Reham A Aboelwafa; Omar M Ghallab
Journal:  Indian J Hematol Blood Transfus       Date:  2017-03-17       Impact factor: 0.900

10.  Rheumatoid arthritis-associated RBPJ polymorphism alters memory CD4+ T cells.

Authors:  William Orent; Allison R Mchenry; Deepak A Rao; Charles White; Hans-Ulrich Klein; Ribal Bassil; Gyan Srivastava; Joseph M Replogle; Towfique Raj; Michael Frangieh; Maria Cimpean; Nicole Cuerdon; Lori Chibnik; Samia J Khoury; Elizabeth W Karlson; Michael B Brenner; Philip De Jager; Elizabeth M Bradshaw; Wassim Elyaman
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.